Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

CME Group (CME) Q2 Earnings Beat Estimates, Increase Y/Y

Published 07/27/2016, 11:02 PM
Updated 07/09/2023, 06:31 AM
NDAQ
-
PGR
-
CME
-
RLI
-

CME Group Inc. (NASDAQ:CME) reported second-quarter 2016 adjusted earnings per share of a record $1.14, which surpassed the Zacks Consensus Estimate of $1.11 by 2.7%. Also, the bottom line improved 15.2% year over year on record average daily volumes.

Including one-time items, net income of 95 cents per share for the quarter increased 21.8% year over year.

The quarter witnessed solid revenue growth, coupled with cost control induced margin expansion and earnings improvement. Management noted four of six product lines that generated more than 20% year-over-year increase in volume and transaction fee revenue.

Behind the Headlines

CME Group’s total revenue grew 10.5% year over year to a record $906.4 million. The improvement was mainly driven by 12.6% higher clearing and transaction fees and 3.7% increase in access and communication fees. Revenues, however, missed the Zacks Consensus Estimate of $911 million.

The company’s average daily volume was a record 15.1 million contracts, up 13% year over year. The company achieved quarterly record in agricultural commodities. In addition, total average rate per contract of 78.2 cents was higher than 77.7 cents in the year-ago quarter.

Total expenses increased 5.6% year over year to $343.1 million during the reported quarter. Operating income jumped 13.8% to $563.3 million.

Financial Update

As of Jun 30, 2016, CME Group had $1.2 billion in cash and marketable securities, down 29.7% from $1.8 billion at year-end 2015. Long-term debt was $2.2 billion, up 0.04% from the 2015-end level.

As of Jun 30, 2016, the company had total assets worth $67.6 billion, up 0.4% from $67.4 billion as of Dec 31, 2015.

Dividend Update

During the quarter, the company paid dividends worth $202 million.

CME GROUP INC Price, Consensus and EPS Surprise

CME GROUP INC Price, Consensus and EPS Surprise | CME GROUP INC Quote

Zacks Rank & Performance of Other Stocks

Currently, CME Group carries a Zacks Rank #3 (Hold). Among the other players from the finance sector that have reported their second-quarter earnings so far, the bottom line at RLI Corp. (NYSE:RLI) and Progressive Corp. (NYSE:PGR) missed their respective Zacks Consensus Estimates, while Nasdaq, Inc.’s (NASDAQ:NDAQ) earnings beat the same.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>



RLI CORP (RLI): Free Stock Analysis Report

PROGRESSIVE COR (PGR): Free Stock Analysis Report

CME GROUP INC (CME): Free Stock Analysis Report

NASDAQ INC (NDAQ): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.